CNSI Incubator member Milo Sensors secures Phase II SBIR funding from NIH

September 25, 2019

Milo Sensors, Inc., a CNSI Technology Incubator company, has secured a $2 million Small Business Innovation Research (SBIR) Phase II grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH).

Bob Lansdorp, CEO and Principal Investigator said of the award, “Alcohol is involved in five percent of all deaths and does immeasurable damage to families and communities. Over $12 Billion is spent on Alcohol Use Disorder treatment every single year in the US alone. We are excited by the opportunity to advance evidence-based alcohol monitoring technology to solve real world problems.”

The peer-reviewed grant will allow the company to accelerate R&D and engineering efforts by hiring experts to join the team and consultants to augment capabilities. The Phase II grant builds on a successful Phase I SBIR grant that was completed in 2018. Half of the award is available in the first year; the rest will come through in year two pending availability of funds and project progress. The grant will support further development of their wearable alcohol sensor technology and fund clinical research to independently validate sensor performance.

Related Links